INS and breast cancer: Evidence from the general non-cancer populations suggest, that sleep duration, nightly fasting duration, and timing of eating, are associated with metabolic (glucose, insulin) and inflammatory (C-Reactive Protein) markers [21–24]—pathways that have been implicated in breast cancer progression [25], further supporting the need to examine these behaviours in breast cancer survivors.